Ticker AQST – Aquestive Therapeutics – sales, description, marketcap – Tickerday.com

AQST

Aquestive Therapeutics

–

Index: NASDAQ; Sector: Healthcare; Industry: Biotechnology & Drugs;

Marketcap: 148.26M; Volume: 2.74M; AvgVol 3m: 1.07M; Beta: –;

Cost estimate:

P/E: –; EPS: -1.78; EPS growth quarter/prev quarter: 91.50%;

EPS growth this year: 11.80%; EPS growth past 5 years: -36.50%;

EPS ttm: -1.78;

P/S: 2.69; P/B: ; P/Cashflow: 6.27; P/FCF: ;

Sales: 59.29M; Sales growth quarter/prev quarter: 95.50%; Sales growth past 5 years: 90.00%;

Profitability:

Gross Margin: 68.60%; Profit Margin: -84.20%; Operating Margin: -66.20%;

ROA – return on assets: -78.20%; ROE – return on equity: 241.10%; LT Debt/Equity: ; Total Debt/Equity: ;

Dividend: –; Dividend Yield (%): –;

Insider Ownership: 5.90%; Insider Transactions:-9.74%;

Institutional Ownership: 55.30%; Institutional Transactions: 5.03%;

Data update: 07/10/2020.